Thursday, June 8, 2023

Kate Therapeutics Raises $51M

San Diego-based Kate Therapeutics has raised $51M in a Series A funding round, the company announced this morning. The funding was co-led by Westlake Village BioPartners and Versant Ventures. According to the company, it is working on next generation genetic medicines for muscle and heart disease. The company is initially looking at addressing myotonic dystrophy type 1 and facioscapulohumeral muscular dystrophy. The funding also included Osage University Partners and UF Innovate | Ventures. Kevin Forrest, Ph.D., is President and CEO of KateTx.